English
Français
Español
Deutsch
Italiano
Português
Nederlands
Polski
Română
Svenska
Dansk
Suomi
Čeština
Ελληνικά
Magyar
SlovenčinaData temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 0/5 criteria met. Data as of 01/11/2026.
- ❌ Price trend failed
- ❌ Growth failed
- ❌ Debt failed
- ❌ P/E failed
- ❌ Correction failed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2018 → 2019: 19.40%
Price change 2019 → 2020: -12.87%
Price change 2020 → 2021: 0.96%
Price change 2021 → 2022: -22.89%
Price change 2022 → 2023: -15.22%
Price change 2023 → 2024: -18.76%
Price change 2024 → 2025: -29.04%
Price change 2025 → 2026: 43.72%
Price change 2026 (year to date): 44.52%
Financial growth
Revenue CAGR (8 years): -7.24%
Earnings CAGR (8 years): N/A
Growth status: insufficient data or negative trend.
Debt
Debt-to-equity ratio: 1.00
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: -109.70
P/E > 25.0 (maximum threshold).
Correction (6 months)
Current correction: 6.11% from the high over 6 months.
Insufficient correction (< 10.0%).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="CLN.SW" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Clariant AG | – | 1.00 | −3.9 % | 🔒 |
| Arkema S.A. | 23.6 | 0.89 | +2.9 % | – |
| Constellium SE | 5.6 | 2.04 | +5.5 % | – |
| Vicat S.A. | 9.2 | 0.57 | +4.4 % | – |
| Vallourec S.A. | 9.4 | 0.40 | −1.1 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by Clariant AG over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2020 | 4.7 bn | 141 m | 3.0 % | n/a |
| 2021 | 5.3 bn | 419 m | 7.9 % | +13.3 % |
| 2022 | 6.3 bn | -123 m | -1.9 % | +18.9 % |
| 2023 | 5.3 bn | 163 m | 3.1 % | -15.8 % |
| 2024 | 5.1 bn | 297 m | 5.9 % | -5.1 % |
| 2025 | 4.8 bn | -91.4 m | -1.9 % | -5.7 % |
Amounts converted to USD. Source: published annual accounts, collected on 06/11/2026.
Accounts and financial health
Balance sheet and cash flow published by Clariant AG over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash and investments | 476 m | 758 m | 593 m | 471 m | 617 m |
| Total Debt | 1.9 bn | 1.5 bn | 1.3 bn | 1.9 bn | 2.0 bn |
| Net Debt | 1.5 bn | 1.1 bn | 861 m | 1.5 bn | 1.6 bn |
| Equity | 2.4 bn | 2.3 bn | 2.0 bn | 2.3 bn | 2.0 bn |
| Total assets | 7.0 bn | 6.2 bn | 5.3 bn | 6.3 bn | 5.9 bn |
| Operating cash flow | 363 m | 502 m | 424 m | 418 m | 379 m |
| Investments (capex) | 360 m | 212 m | 204 m | 207 m | 146 m |
| Free cash-flow | 3.0 m | 290 m | 214 m | 209 m | 234 m |
| Share buybacks | 16.0 m | 8.0 m | 8.0 m | 14.0 m | 0 |
| Dividends paid | 230 m | 132 m | 138 m | 139 m | 138 m |
Amounts in CHF, currency of the published accounts.
Trailing 12-month ratios
Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 09/11/2026.
Valuation and competitors
Clariant AG compared with its sector on the same exchange and with its main competitors.
Direct competitors
| Company | Market cap (USD) | P/E | Net margin |
|---|---|---|---|
| Clariant AG | 4.1 bn | n/a | -1.9 % |
| Dottikon Es Holding AG DESN.SW | 4.8 bn | 37.8 | 24.2 % |
| Ems-Chemie Holding AG EMSN.SW | 23.9 bn | 42.2 | 23.9 % |
| Gurit Holding AG GURN.SW | 269 m | 13.1 | -18.9 % |
| Sika AG SIKA.SW | 34.9 bn | 27.3 | 9.3 % |
| Givaudan S.A. GIVN.SW | 44.5 bn | 38.0 | 14.3 % |
Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 06/11/2026. Competitors: comparable companies named by the data provider.
Who owns the stock
Free float, institutional investors, large funds, executives and elected officials: declared positions in Clariant AG.
Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 31/10/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about Clariant AG
What is the Clariant AG share price?
Latest recorded price: 10.70 CHF on 06/11/2026, for a market cap of 4.3 bn USD.
What is the revenue of Clariant AG?
4.8 bn USD for fiscal year 2025, with net income of -91.4 m USD (net margin -1.9 %).
Is Clariant AG stock eligible for the French PEA?
No: the company is headquartered outside the European Union and the European Economic Area (ISIN CH0012142631).
How many employees does Clariant AG have?
10,465 full-time employees according to the latest published profile.
Who runs Clariant AG?
Conrad Keijzer is the company's chief executive.